Maravai Lifesciences Holdings (MRVI) Cash from Operations (2020 - 2026)

Maravai Lifesciences Holdings' Cash from Operations history runs 7 years deep, the most recent figure standing at 8665000.0 for Q1 2026.

• In Q1 2026, Cash from Operations rose 192.28% year-over-year to 8665000.0; the TTM figure through Mar 2026 stood at 39518000.0 (down 704.07% YoY), while the FY2025 annual figure was 57573000.0, down 871.24% from the prior year.
• Cash from Operations for Q1 2026 stood at 8665000.0, up from 22768000.0 in the prior quarter.
• The five-year high for Cash from Operations was 164279000.0 in Q2 2022, with the low at 22768000.0 in Q4 2025.
• The 5-year median for Cash from Operations is 13136000.0 (2024), against an average of 36515176.47.
• The sharpest annual moves came in 2022 and 2024: Cash from Operations jumped 323.48% in 2022, then plunged 287.91% in 2024.
• Maravai Lifesciences Holdings' Cash from Operations stood at 99335000.0 in 2022, then plunged by 92.16% to 7790000.0 in 2023, then slumped by 287.91% to 14638000.0 in 2024, then plunged by 55.54% to 22768000.0 in 2025, then surged by 138.06% to 8665000.0 in 2026.
• Business Quant data shows MRVI's Cash from Operations at 8665000.0 in Q1 2026, 22768000.0 in Q4 2025, and 15150000.0 in Q3 2025.